Analyze Diet

Topic:Vaccine development

Vaccine development in horses involves the creation and refinement of immunizations to protect equine populations from infectious diseases. This process includes identifying antigens, formulating vaccines, and evaluating their safety and efficacy through clinical trials. Vaccines stimulate the horse's immune system to recognize and combat specific pathogens, thereby reducing the incidence and severity of diseases. Common equine vaccines target diseases such as equine influenza, tetanus, and West Nile virus. This page compiles peer-reviewed research studies and scholarly articles that explore the methodologies, challenges, and advancements in vaccine development for equine health.
Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; anaphylactogenic properties of typhus fever vaccines and equine encephalomyelitic vaccines.
Journal of immunology (Baltimore, Md. : 1950)    August 1, 1946   Volume 53 321-342 
COULSON EJ, STEVENS H.No abstract available
Equine Infectious Anaemia: Attempted Vaccination with Crystal Violet Tissue Vaccine.
Canadian journal of comparative medicine and veterinary science    July 1, 1945   Volume 9, Issue 7 197-199 
Bankier JC.No abstract available
Experiments on the Transmission of an Icterogenic Agent in Yellow Fever Vaccine to Horses and Swine.
Journal of bacteriology    July 1, 1944   Volume 48, Issue 1 45-69 doi: 10.1128/jb.48.1.45-69.1944
Carle BN, Dewhirst WH, Braun W, Eaton MD.No abstract available
Protective Vaccination of Horses with Modified Equine Encephalomyelitis Virus.
Science (New York, N.Y.)    June 7, 1935   Volume 81, Issue 2110 572 doi: 10.1126/science.81.2110.572
Traub E, Broeck CT.No abstract available
EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES.
The Journal of experimental medicine    May 31, 1928   Volume 47, Issue 6 835-841 doi: 10.1084/jem.47.6.835
Olitsky PK, Long PH.The virus of vesicular stomatitis is not readily killed by formalin. This chemical is one of a group which coagulates the proteins of the medium in which the virus is usually contained. It has already been found(7) that other reagents of the protein-coagulating group are not actively virucidal) and the effect of formalin in this instance is therefore characteristic of the group. The so called formalinized vaccines which give rise to immunity can be shown to have done so because of the presence of living virus. A single injection of such so called "vaccine," or of other material containing livi...
Equine arteritis virus.
   April 10, 2026  
Equine arteritis virus (EAV) is the causative agent of equine viral arteritis (EVA), a respiratory and reproductive disease of equids. There has been significant recent progress in understanding the molecular biology of EAV and the pathogenesis of its infection in horses. In particular, the use of contemporary genomic techniques, along with the development and reverse genetic manipulation of infectious cDNA clones of several strains of EAV, has generated significant novel information regarding the basic molecular biology of the virus. Therefore, the objective of this review is to summarize cur...
Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine.
   April 10, 2026  
A clinical evaluation of a new, purified, heat-treated equine rabies immunoglobulin (PHT-Erig), F(ab')2 preparation, was carried out in Thailand and in the Philippines-two countries where rabies is endemic. An initial prospective, randomised, controlled trial (Study 1), compared the safety and pharmacokinetics (serum concentrations of rabies antibodies) after administration either of PHT-Erig or of a commercially-available, equine rabies immune globulin (Erig PMC). A second trial (Study 2) simulated post-exposure rabies prophylaxis by using a reference cell culture vaccine, the purified Vero-c...
1 33 34 35